Thursday, September 8, 2011

Relative political unknown Noda to take over 'daunting task': NYT


NEW YORK, Aug. 29 Kyodo


Meanwhile, The Wall Street Journal said that Noda, who has advocated a temporary tax hike to finance reconstruction from the March 11 disaster, is seen by economists and political analysts as a ''steady hand.'' His stance was welcomed by the bond market, which saw a downgrading of Japanese sovereign debt last week, it said.The two papers said Noda will likely see improvements in the running of Diet affairs because of his willingness to cooperate with the Liberal Democratic Party and other opposition forces, which are capable of blocking most bills due to their control of the House of Councillors.of Japan, The New York Times reported Monday.''Mr. Noda will take over the daunting tasks of leading Japan's recovery from the deadly earthquake and the clean-up of radiation from the stricken Fukushima Daiichi nuclear plant, while also overcoming the challenges of two decades of economic stagnation, an aging population and the rise of neighboring China,'' the daily said in its electronic version.It said that Noda, who lacks a large power base within the party and was seen running a distant third before the DPJ's lawmakers voted Monday, scored a ''surprise victory'' and that the DPJ was apparently signaling an ''effort to move beyond deep divisions that have undermined the party.''Japanese Finance Minister Yoshihiko Noda, who has been elected to lead the ruling Democratic Party of Japan, is a relative political unknown who faces heavy responsibility as the next prime minister

But on the diplomatic front, Noda could increase frictions with China and other Asian countries because of his position that Japan's wartime leaders were not war criminals, the reports said.




Toshiba’s Aquilion ONE Dynamic Volume and Perfusion Imaging Technologies Improve Head and Neck Tumor Diagnoses


Toshiba Showcases the Aquilion ONE at the American Society of Head and Neck Radiology’s Annual Meeting


“The advanced imaging capabilities of the Aquilion ONE not only capture high-quality images of anatomy but also changes in that anatomy over time,” said Joseph Cooper, director, CT Business Unit, Toshiba. “For patients requiring perfusion imaging to determine a head or neck tumor’s malignancy, the Aquilion ONE allows a physician to see blood flow in real time, enabling greater visualization and more complete diagnosis for improved patient care.”Toshiba is a diversified manufacturer and marketer of advanced electronic and electrical products, spanning digital products, such as LCD TVs, notebook PCs and hard disc drives; electronic devices and components, such as semiconductors; social infrastructure systems, including power generation systems and home appliances. Toshiba was founded in 1875, and today operates a global network of more than 490 companies, with 203,000 employees worldwide and annual sales surpassing 6.3 trillion yen (US$77 billion).Also at ASHNR, Toshiba will sponsor a lunch-and-learn presentation, “320 Detector Row Head and Neck Imaging: Unique Benefits including Functional Imaging,” presented by Dr. Keith Peters, UF College of Medicine associate professor of radiology and neurological surgery. The presentation will take place on Thursday, September 8, 2011, at 12:00 p.m. PT, Hotel del Coronado, San Diego.Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine, and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba.About ToshibaAbout Toshiba America Medical Systems, Inc.Unlike any other CT system available, the Aquilion ONE covers up to 16 cm of anatomy using 320 ultra-high-resolution 0.5 mm detector elements. With the Aquilion ONE, clinicians can use its advanced perfusion imaging capabilities to visualize and quantify blood flow, as well as determine the stage, location and treatment path for patients.About Toshiba Medical Systems CorporationTUSTIN, Calif. -- When diagnosing and planning treatment for head or neck tumors, clinicians require a CT system that is able to identify diseases and malignancies with high accuracy. Toshiba America Medical Systems, Inc.’s AquilionTM ONE CT system has the unique ability to show dynamic blood flow and real-time function, improving diagnostic accuracy, while making imaging safer by limiting radiation dose. Toshiba will showcase these capabilities during the American Society of Head and Neck Radiology’s (ASHNR) annual meeting, September 7 – 11, in San Diego.

Toshiba is a diversified manufacturer and marketer of advanced electronic and electrical products, spanning digital products, such as LCD TVs, notebook PCs and hard disc drives; electronic devices and components, such as semiconductors; social infrastructure systems, including power generation systems and home appliances. Toshiba was founded in 1875, and today operates a global network of more than 490 companies, with 203,000 employees worldwide and annual sales surpassing 6.3 trillion yen (US$77 billion).




Wednesday, September 7, 2011

Aeolus to Present at Stifel Nicolaus' Annual Healthcare Conference


Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company that is leveraging up to $140M of government funding in developing a platform of a new class of broad-spectrum catalytic antioxidant compounds as medical countermeasures to radiation exposure to develop them in oncology indications, today announced that it will be presenting at the Stifel Nicolaus Annual Healthcare Conference in Boston. Russell Skibsted, the Company's Chief Financial Officer, will be presenting a corporate update, including an overview of its recent contract with the Biomedical Advanced Research and Development Authority (BARDA), with options valued at $118 million.


Company Contact Russell Skibsted Chief Financial Officer Aeolus Pharmaceuticals, Inc. 949-481-9821Forward-Looking Statements The statements in this press release that are not purely statements of historical fact are forward-looking statements. Such statements include, but are not limited to, those relating to Aeolus' product candidates, as well as its proprietary technologies and research programs. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Aeolus' actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Important factors that could cause results to differ include risks associated with uncertainties of progress and timing of clinical trials, scientific research and product development activities, difficulties or delays in development, testing, obtaining regulatory approval, the need to obtain funding for pre-clinical and clinical trials and operations, the scope and validity of intellectual property protection for Aeolus' product candidates, proprietary technologies and their uses, and competition from other biopharmaceutical companies. Certain of these factors and others are more fully described in Aeolus' filings with the Securities and Exchange Commission, including, but not limited to, Aeolus' amended Annual Report on Form 10-K/A for the year ended September 30, 2010. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.About Aeolus Pharmaceuticals Aeolus Pharmaceuticals is developing a new class of catalytic antioxidant compounds that protects healthy tissue from the damaging effects of radiation. Its first compound, AEOL 10150, is being developed for oncology indications, where it is used in combination with radiation therapy. It is also being developed, with funding by the US Government, as a medical countermeasure against chemical and radiological weapons, where its initial target indications are as a protective agent against the effects of acute radiation syndrome and delayed effects of acute radiation exposure. Aeolus' strategy is to leverage the substantial investment in toxicology, manufacturing, and preclinical and clinical studies made by US Government agencies in AEOL 10150, including the contract with BARDA valued, with options, at up to $118 million, to efficiently develop the compound for use in oncology.

Company Contact Russell Skibsted Chief Financial Officer Aeolus Pharmaceuticals, Inc. 949-481-9821




Top 10 home efficiency tips; SAVING ENERGY


HOUSEHOLD energy costs have doubled in six years and the latest round of increases will add around pounds 200 extra to your bills each year.


The Heating Helpline has released 10 tips to help cut energy costs.8) Appliances left on 'standby' can waste up to pounds 100 of energy a year. Unplug to save money. 9) Turn your washing machine down to 40-30C and cut energy usage by 40%.6) Draught proofing doors, windows and attic entrances by sealing gaps saves energy; as do heavy, well-fitted curtains over windows and doors.2) Fitting a jacket to the boiler could save over pounds 50 a year. 3) Most people's thermostats are set higher than they need to be to keep comfortably warm. Set room thermostats to no more than 21C (70F).7) Heat rises so upgraded insulation in the roof space will reduce heat loss. 27cm of insulation could save you up to pounds 150 a year.4) Consider fitting a programmable thermostat that lets you choose the time you want your heating on and the temperature for all seven days of the week.5) Thermostatic radiator valves (costing pounds 8 each) let you control the temperature in each room to avoid wasting energy.1) The hot water cylinder thermostat should be set at 60C (140F). Any higher is a waste of energy, but any lower carries a risk of legionella.

10) When using the kettle only boil the amount of water you need.




Tuesday, September 6, 2011

Runner finishes near bottom of American Discovery Trail event, and


All runners have their own motivation, especially those who travel long distances.


"My big goal was to PR, to be in the top three and to break 3 hours," said Howard, who earned a doctorate in physical therapy from Northern Arizona. "I ran this race last year and finished second, so I was happy to improve my time by 6 minutes and to win it."Mudry, 24, and Nichols recently returned from three months of shooting footage in Kenya for a documentary titled "Where Dreams Don't Fade," a film that captures the flavor of what fuels Kenyan runners to become world-class athletes."I'm not fast, and I might be one of the last people in, but I'm lucky," Smith said. "This is my way of flipping cancer off. Every day I get to train and run, it's a good day. Everybody races their own race."Three years ago, those two words blindsided the former psychotherapist, who lived in Denver at the time, as ovarian cancer had invaded her body. Monday, some two years after being declared cancer free - thanks to 30 rounds of radiation, 12 cycles of chemotherapy and three surgeries - Smith didn't put much stock into the time it took to complete more than 13 miles.Alexis Smith, of Colorado Springs, has plenty of motivation, summed up by two words expressed as she crossed the finish line in 350th place Monday in the half marathon version of the American Discovery Trail event that concluded at America the Beautiful Park.Note quite 3 hours, but she'll take it.For Martin Mudry, his race motivation was eclipsing the marathon course mark set last year by roommate Alex Nichols, a Colorado College graduate.Time has a funny way of adjusting one's perspective."The idea was to follow where people pursue their dreams for a long period of time," Mudry said. "Kenyans do that. They have a huge level of self confidence. They have a dream of being a champion, and they go after it for five or 10 years, even without having a job, and keep pursuing it even if it's not going well. That's a big part of what we show.""I decided to go after his ghost today," said Mudry, who completed the 26.2-mile trek from Palmer Lake in 2 hours, 32 minutes and 53 seconds.He didn't, but winning the overall title took away any hint of disappointment.Monday's race went well, too, for Sharon Howard of Aurora, who was the first female to finish the marathon(3:01:01).Mudry, who spent one year at Colorado College before finishing his undergraduate work at Macalester College in St. Paul, Minn., said he hopes to launch the film early next year.

"My big goal was to PR, to be in the top three and to break 3 hours," said Howard, who earned a doctorate in physical therapy from Northern Arizona. "I ran this race last year and finished second, so I was happy to improve my time by 6 minutes and to win it."




New Reimbursement Codes for Intra-Operative Radiation Therapy (IORT)


Reimbursement Codes effective January 1, 2012 will cover cancer patients for additional treatment options


“We are pleased that the AMA and ASTRO supported these codes for electron IORT. By approving new CPT codes for electron IORT procedures, patients will have greater access to a single, two minute, radiation treatment during surgery. These patients will benefit from a reduction of up to seven weeks of external beam radiation, also reducing the toxicity of their treatment and providing a quick return their normal lives.” said John Powers, Chief Executive Officer of IntraOp. “We anticipate that these new codes will increase patient awareness and availability of electron IORT to cancer patients throughout the United States.”IntraOp Medical Corporation provides innovative technology solutions for the treatment and eradication of cancer. The IntraOp Mobetron is a patented, self-shielded, mobile, linear accelerator that allows hospitals to provide electron IORT in existing operating rooms at the time of surgery. Mobetron benefits include: increased survival rates, better local tumor control, shorter treatment cycles, and fewer side effects. Centers of excellence in North America, Europe and Asia, use the Mobetron as a vital part of their comprehensive cancer program. The Mobetron is used to effectively treat over 20 different cancer indications.For more information on IntraOp Medical Corporation, please visit www.intraopmedical.comAbout IntraOp

For more information on IntraOp Medical Corporation, please visit www.intraopmedical.com




Monday, September 5, 2011

Curtiss-Wright Controls Electronic Systems Introduces New 3U OpenVPX Smart Power Supply


Curtiss-Wright Controls Electronic Systems (CWCES), a business group of Curtiss-Wright Controls and a leading designer and manufacturer of rugged deployed subsystems for the aerospace, defense and commercial markets, has introduced a new 3U OpenVPX (VITA 62) and VPX (VITA 48.2) Smart Power Supply . This small form factor, rugged power supply module provides up to 279W of power to mission critical OpenVPX systems. Designed for demanding deployed military applications, the CWCES Smart Power Supply includes advanced features such as an integrated Nuclear Event Detector (NED) and crowbar for radiation tolerant applications, and a holdup circuitry for full protection against MIL-STD-704 and MIL-STD-1275 transients. This open architecture smart power supply module speeds and simplifies the integration and maintenance of intelligent rugged power supplies into applications such as ground vehicles, fixed wing aircraft and rotorcraft, shipboard equipment, and integrated modular systems.


Note: All trademarks are property of their respective owners.About Curtiss-Wright Controls, Inc. Headquartered in Charlotte, N.C., Curtiss-Wright Controls is the motion control segment of Curtiss-Wright Corporation. With manufacturing facilities around the world, Curtiss-Wright Controls is a leading technology-based organization providing niche motion control products, subsystems and services internationally for the aerospace and defense markets. For more information, visit www.cwcontrols.com ."Our new 3U OpenVPX power supply provides system integrators with a rugged, compact high performance power supply able to survive the harshest military environments, while providing all the benefits of the VPX backplane architecture," said David Dietz, vice president and general manager of Curtiss-Wright Controls Electronic Systems group.Sales Contact Please forward all sales and reader service inquiries to Curtiss-Wright Controls Electronic Systems Tel: (661) 257-4430 email: Email Contact Editorial Contact For editorial information regarding Curtiss-Wright Controls Electronic Systems, contact John Wranovics Public Relations Director Curtiss-Wright Controls Tel: (925) 640-6402 email: Email ContactThis fully-featured intelligent power supply supports Built-in Tests (BIT) and software programmability to enable rapid system development.CWCES Smart Power Supply Performance Features:About Curtiss-Wright Controls Electronic Systems Curtiss-Wright Controls Electronic Systems is one of the industry's most comprehensive and experienced single sources for rugged, integrated electronic system solutions. Our product and service expertise includes mission and flight control computer systems ; network centric computing systems; avionics and Vetronics processor units; motion control solutions and rate sensor assemblies; rugged high-speed data recorders and storage devices ; engineered packaging (including chassis/enclosures, power supplies, subracks and backplanes) ; smart power control and distribution systems ; sensor management systems ; electric turret drive, stabilization, and ammunition handling systems; and electro-mechanical solutions . The Electronic Systems group serves the defense, aerospace, commercial and industrial markets and is part of Curtiss-Wright Controls Inc. For more information about Curtiss-Wright Controls Electronic Systems, visit www.cwcelectronicsystems.com .3U VPX (VITA 48.2/62) form factor Up to 279W total rated power 80% efficiency 18-36 VDC input range MIL-STD-704 and MIL-STD-1275 compliant Meets NAVSO P-3641 de-rating Internal holdup up to 50 ms EMI/RFI input filter (MIL-STD-461E) Input transient (surge) protection Input reverse polarity protection Over/under voltage, short-circuit and under/over temperature protection White Sand Missile Range (WSMR)-tested Nuclear Event Circumvention circuit On-board ARM-based microcontroller I2C communication Inline voltage/current monitoring and BIT Suitable for OpenVPX and VPX systems Custom power sequencingFor additional product information on the 3U OpenVPX power supply and to download the factsheet, please visit: http://www.cwcelectronicsystems.com/3u_vpx_powersupply.html

Sales Contact Please forward all sales and reader service inquiries to Curtiss-Wright Controls Electronic Systems Tel: (661) 257-4430 email: Email Contact Editorial Contact For editorial information regarding Curtiss-Wright Controls Electronic Systems, contact John Wranovics Public Relations Director Curtiss-Wright Controls Tel: (925) 640-6402 email: Email Contact